Inventor · disambiguated record
Kevin Pinz
Also filed as: PINZ KEVIN
6 granted patents·16 pending applications·40 citations·filing 2016–2024
81Inventor score
Files withICELL GENE THERAPEUTICS LLC11ICELL GENE THERAPEUTICS INC6iCell Gene Therapeuticics LLC4iCell Gene Therapeutjics LLC1
Top patents by PatentIndex Score
22 records- 0192US10273280B2Chimeric antigen receptors (CARs), targeting hematologic malignancies, compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2016·Granted Apr 30, 2019·18 cites·20 claims
- 0290US11820819B2Chimeric antigen receptors (CARs), compositions and methods thereofICELL GENE THERAPEUTICS LLC·Filed 2017·Granted Nov 21, 2023·5 cites·5 claims
- 0389US11655452B2Chimeric antigen receptors (CARs), compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2016·Granted May 23, 2023·6 cites·4 claims
- 0489US11173179B2Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2018·Granted Nov 16, 2021·6 cites·1 claims
- 0587US11905528B2Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereofICELL GENE THERAPEUTICS LLC·Filed 2018·Granted Feb 20, 2024·3 cites·7 claims
- 0682US12275787B2Chimeric antigen receptors (CARs), compositions and methods thereofICELL GENE THERAPEUTICS LLC·Filed 2018·Granted Apr 15, 2025·2 cites·2 claims
- 0779US2024141041A1CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOFICELL GENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0875US2023340113A1CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOFICELL GENE THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 0973US2024124547A1CHIMERIC ANTIGEN RECEPTORS (CARs) TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOFiCell Gene Therapeuticics LLC·Filed 2023·Application pending·0 cites
- 1072US2025002550A1Compound chimeric antigen receptor (ccar) targeting multiple antigens, compositions and methods of use thereofICELL GENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1164US2024059754A1Chimeric antigen receptors and enhancement of anti-tumor activityiCell Gene Therapeutjics LLC·Filed 2022·Application pending·0 cites
- 1264US2024350632A1Engineered immune cells for treating disorders, compositions and methods thereofICELL GENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1361US2020283534A1CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOFiCell Gene Therapeuticics LLC·Filed 2016·Application pending·0 cites
- 1460US2023277622A1CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS THEREOFICELL GENE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1560US2023302051A1CHIMERIC ANTIGEN RECEPTORS (CARs), TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOFICELL GENE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1658US2022348633A1COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOFICELL GENE THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1755US2022241327A1Chimeric Antigen Receptor (CAR) Targeting Multiple Antigens, Compositions and Methods of Use ThereofICELL GENE THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 1855US2019345217A1CHIMERIC ANTIGEN RECEPTORS (CARs) TARGETING HEMATOLOGIC MALIGNANCIES, COMPOSITIONS AND METHODS OF USE THEREOFiCell Gene Therapeuticics LLC·Filed 2019·Application pending·0 cites
- 1953US2024261401A1Engineered immune cells, compositions and methods thereofICELL GENE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2052US2021338729A1CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOFICELL GENE THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2149US2018371052A1Chimeric antigen receptors and enhancement of anti-tumor activityICELL GENE THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
- 2245US2019135894A1COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHODS OF USE THEREOFiCell Gene Therapeuticics LLC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Pinz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →